Evidence map›Paper›PMID 29740748›Full record

ArticleNeurochemical research2018

The Effects of Chronic Amitriptyline on Zebrafish Behavior and Monoamine Neurochemistry.

Darya A Meshalkina, Elana V Kysil, Kristina A Antonova, Konstantin A Demin, Tatiana O Kolesnikova, Sergey L Khatsko, Raul R Gainetdinov, Polina A Alekseeva, Allan V Kalueff

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Current State of Modeling Human Psychiatric Disorders Using Zebrafish.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Darya A MeshalkinaInstitute of Translational Biomedicine, St. Petersburg University, St. Petersburg, Russia.
Elana V KysilInstitute of Translational Biomedicine, St. Petersburg University, St. Petersburg, Russia.
Kristina A AntonovaInstitute of Translational Biomedicine, St. Petersburg University, St. Petersburg, Russia.
Konstantin A DeminInstitute of Translational Biomedicine, St. Petersburg University, St. Petersburg, Russia.
Tatiana O KolesnikovaUral Federal University, Ekaterinburg, Russia.
Sergey L KhatskoUral Federal University, Ekaterinburg, Russia.
Raul R GainetdinovInstitute of Translational Biomedicine, St. Petersburg University, St. Petersburg, Russia.
Polina A AlekseevaInstitute of Experimental Medicine, Almazov National Medical Research Centre, St. Petersburg, Russia.
Allan V KalueffSchool of Pharmaceutical Sciences, Southwest University, Chongqing, China. avkalueff@gmail.com.
St Petersburg University · RUFederal Almazov North-West Medical Research Centre · RUUral Federal University · RUSouthwest University · CN

Funding

Russian Foundation for Basic Research 16-04-00851Russian Foundation for Basic Research 18-315-00375
6 · The paper itself

Abstract

Amitriptyline is a commonly used tricyclic antidepressant (TCA) inhibiting serotonin and norepinephrine reuptake. The exact CNS action of TCAs remains poorly understood, necessitating new screening approaches and novel model organisms. Zebrafish (Danio rerio) are rapidly emerging as a promising tool for pharmacological research of antidepressants, including amitriptyline. Here, we examine the effects of chronic 2-week exposure to 10 and 50 μg/L amitriptyline on zebrafish behavior and monoamine neurotransmitters. Overall, the drug at 50 μg/L evoked pronounced anxiolytic-like effects in the novel tank test (assessed by more time in top, fewer transition and shorter latency to enter the top). Like other TCAs, amitriptyline reduced serotonin turnover, but also significantly elevated whole-brain norepinephrine and dopamine levels. The latter effect was not reported in this model previously, and accompanied higher brain expression of tyrosine hydroxylase (a rate-limiting enzyme of catecholamine biosynthesis), but unaltered expression of dopamine-β-hydroxylase and monoamine oxidase (the enzymes of dopamine metabolism). This response may underlie chronic amitriptyline action on dopamine and norepinephrine neurotransmission, and contribute to the complex CNS profile of this drug observed both clinically and in animal models. Collectively, these findings also confirm the important role of monoamine modulation in the regulation of anxiety-related behavior in zebrafish, and support the utility of this organism as a promising in-vivo model for CNS drug screening.

Indexed as

AnimalsAnti-Anxiety AgentsAntidepressive AgentsAntidepressive Agents, TricyclicBehavior, AnimalBrainNervous System Physiological PhenomenaNeurochemistryNorepinephrineSynaptic TransmissionTyrosine 3-MonooxygenaseZebrafishAnti-Anxiety AgentsAntidepressive AgentsAntidepressive Agents, TricyclicNorepinephrineTyrosine 3-MonooxygenaseAmitriptylineDopamineNorephnephrineSerotoninTricyclic antidepressantsZebrafish

Identifiers

PMID29740748
OpenAlexW2801432909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.